The FDA granted accelerated approval to the combination of avutometinib and defactinib (Avmapki Fakzynja Co-pack) for the treatment of adults with KRAS -mutated, recurrent low-grade serous ovarian ...

The FDA has granted accelerated approval to avutometinib (VS-6766) plus defactinib (VS-6063) for the treatment of adult ...

Treatment with the Avmapki Fakzynja Co-pack received accelerated FDA approval for previously treated low-grade serous ovarian ...

Discover how clove tea's compounds provide benefits from pain relief to blood sugar management that might make this aromatic ...

Pronounced “soh-TIK-too,” SOTYKTU is a once-daily pill for adults with moderate to severe plaque psoriasis that works inside ...

Discover natural treatments to banish persistent acne without harsh chemicals, from anti-inflammatory ingredients to ...

Q1 2025 Earnings Call Transcript May 7, 2025 EyePoint Pharmaceuticals, Inc. reports earnings inline with expectations. Reported EPS is $-0.65 EPS, expectations were $-0.65. Operator: Good morning. My ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

If you’ve been milking goats for any length of time, you’ve likely dealt with mastitis, plugged ducts, or flaky milk at some ...

In this single-arm trial, the median overall survival (OS) observed was 4.0 months (95% CI: 2.5-7.2) among all 64 adults in the primary efficacy analysis based on the Kaplan-Meier estimate. The median ...

Share….Lagos seeks increased investment as game changer I n celebration of the 2025 International Day of the Midwife, the ...